US Dollar vs MXN

Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

Regístrate

CVGR

Covalent (CVGR)

Covalent

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CVGR

1 2 3 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
30/10/2006	10:34	Business Wire	Covalent Group Changes Name to Encorium Group, Inc.	NASDAQ:CVGR	Covalent
20/10/2006	15:08	Business Wire	Covalent Group, Inc. Announces Results of Shareholder Vote	NASDAQ:CVGR	Covalent
19/10/2006	07:01	Business Wire	Covalent Signs $8.2 Million in Contracts For Multinational Studies to Treat Influenza	NASDAQ:CVGR	Covalent
08/08/2006	15:36	Business Wire	Covalent Reports 2006 Second Quarter Financial Results; Company to Hold Conference Call at 9:00 AM on Wednesday, August 9, 2006	NASDAQ:CVGR	Covalent
07/08/2006	07:24	Business Wire	Covalent Group, Inc. Announces $1.7 Million Contract For Phase 2 Clinical Trial in Atherosclerosis	NASDAQ:CVGR	Covalent
02/08/2006	09:14	Business Wire	Covalent Group, Inc. Schedules Second Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
13/07/2006	11:00	Business Wire	Covalent Group, Inc. Signs Contracts Totaling $1.5 Million for Clinical Studies Offering Advanced Therapeutic Approaches to Pat	NASDAQ:CVGR	Covalent
06/07/2006	13:15	Business Wire	Covalent Group Amends Business Combination Agreement with Remedium Oy	NASDAQ:CVGR	Covalent
28/06/2006	07:27	Business Wire	Covalent Group, Inc. Announces $2.1 Million of New Business Contracts; Reiterates Second Quarter Guidance	NASDAQ:CVGR	Covalent
15/05/2006	16:22	Business Wire	Covalent Reports 2006 First Quarter Financial Results and Summary Balance Sheet Data; Company to Hold Conference Call at 9:00 A	NASDAQ:CVGR	Covalent
08/05/2006	07:12	Business Wire	Covalent Group, Inc. Schedules First Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
20/04/2006	07:07	Business Wire	Covalent Group, Inc. Signs $1 Million Contract To Conduct Phase 1 Study of Drug to Prevent/Treat Infectious Disease	NASDAQ:CVGR	Covalent
30/03/2006	07:00	Business Wire	Covalent Group, Inc. Announces Additional New Business Contracts	NASDAQ:CVGR	Covalent
21/03/2006	16:15	Business Wire	Covalent Group, Inc. Announces $2.1 Million Contract To Conduct Patient Disease Registry In Hospitalized Subjects With Hyponatr	NASDAQ:CVGR	Covalent
21/03/2006	16:14	Business Wire	Covalent Group, Inc. Signs $1.3 Million in Consulting and Medical Writing Contracts to Support New Drug Applications (NDA) for	NASDAQ:CVGR	Covalent
21/03/2006	16:12	Business Wire	Covalent Reports 2005 Fourth Quarter and Year End Financial Results and Summary Balance Sheet Data; Company to Hold Conference	NASDAQ:CVGR	Covalent
16/03/2006	06:57	Business Wire	Covalent Group, Inc. Schedules Fourth Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
03/03/2006	07:12	Business Wire	Covalent Group, Inc. Enters into Combination Agreement with Remedium Oy; Conference Call Scheduled for 11:00 AM ET Today	NASDAQ:CVGR	Covalent
08/02/2006	08:31	Business Wire	Covalent Group, Inc. and Sudler & Hennessey Announce Strategic Partnership to Design and Conduct Global Patient Disease Registri	NASDAQ:CVGR	Covalent
02/02/2006	07:01	Business Wire	Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients with Cardiovascular Dise	NASDAQ:CVGR	Covalent
31/01/2006	11:00	Business Wire	Covalent Group, Inc. Retains The Equity Group to Provide Investor Relations Services	NASDAQ:CVGR	Covalent
24/01/2006	07:00	PR Newswire (US)	Covalent Group, Inc. Announces Multiple New Business Contracts with an Aggregate Value of $1.0 Million	NASDAQ:CVGR	Covalent
18/01/2006	07:00	PR Newswire (US)	Covalent Group, Inc. Signs Contract for $2.3 Million to Conduct a Multinational Phase 2 Clinical Trial Involving a New Antithrom	NASDAQ:CVGR	Covalent
08/12/2005	06:00	PR Newswire (US)	Covalent Group, Inc. Signs Letter-of-Intent to Conduct $2.2 Million Multinational Phase 2 Clinical Trial in Cardiovascular Disea	NASDAQ:CVGR	Covalent
05/12/2005	06:01	PR Newswire (US)	Covalent Group, Inc. and Emergent BioSolutions Sign Contract to Develop Immune Globulins for Treatment Exposure of Anthrax Infec	NASDAQ:CVGR	Covalent
18/11/2005	08:30	PR Newswire (US)	CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial	NASDAQ:CVGR	Covalent
11/11/2005	09:20	PR Newswire (US)	/C O R R E C T I O N -- Covalent Group, Inc. /	NASDAQ:CVGR	Covalent
10/11/2005	16:01	PR Newswire (US)	Covalent Reports Results for Third Quarter 2005	NASDAQ:CVGR	Covalent
07/11/2005	07:03	PR Newswire (US)	Covalent Group, Inc. to Report Third Quarter 2005 Results on Thursday, November 10	NASDAQ:CVGR	Covalent
06/10/2005	08:01	PR Newswire (US)	Covalent Group, Inc. Announces $5.3 Million Contract to Provide Additional Services for a Global Phase 3 Trial in Hypertension	NASDAQ:CVGR	Covalent

Showing the most relevant articles for your search:NASDAQ:CVGR

1 2 3 Próxima >

Energy Select Sector SPDR

JP Morgan Chase

Health Care Select Sector

Invesco QQQ Trust Series 1

Gold vs US Dollar

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones